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Purpose: Normal tension glaucoma (NTG) is a subtype of glaucoma in which intraocular pressure is within the statistically
normal range. NTG may be associated with an immune disorder. The aim of this study was to determine whether specific
alleles in the human leukocyte antigen (HLA)-DRB1 and HLA-DQB1 genes correlated with NTG in Japanese patients.
Methods: We genotyped the HLA-DRB1 and HLA-DQB1 alleles in 113 Japanese patients with NTG and in 184 healthy
Japanese control subjects using the polymerase chain reaction-sequence-specific oligonucleotide probes (PCR-SSOP)
Luminex method. We assessed the allelic diversity in patients and controls.
Results: There were no statistically significant differences in the allele frequency of HLADRB1 and HLA-DQB1 between
NTG patients and control subjects, and no HLA-DRB1-HLA-DQB1 haplotypes demonstrated any significant association
with NTG.
Conclusions: Our findings suggest that HLA-DRB1 and HLA-DQB1 polymorphisms have no significant effect on the
development of NTG in Japanese patients.
Glaucoma is a progressive optic neuropathy leading to
permanent visual loss that affects approximately 70 million
people worldwide [1,2]. The most common type of glaucoma
is  primary  open  angle  glaucoma  (POAG).  Glaucoma  is
generally a multifactorial disorder caused by environmental
and/or genetic factors. High intraocular pressure (IOP) is the
most important risk factor for glaucoma [3] and has previously
been used as a diagnostic criterion for the disease. A subset of
patients with POAG have normal IOP, a condition called
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normal tension glaucoma (NTG) [4-6]; thus, factors other than
IOP clearly influence the pathogenesis of glaucomatous optic
neuropathy. The prevalence of NTG is 3.6% in Japan, which
is  higher  than  in  other  ethnicities  [7].  NTG  often  goes
undiagnosed  until  after  vision  deteriorates  because  the
symptoms are minimal and IOP is normal. Although relatively
higher IOP, myopia, and older age are known to be factors
associated with the development of NTG [8], they are not
pathognomonic. Other pathogenic factors such as vasospasm,
ischemia, and vascular insufficiencies are also indicated to be
associated with the development of NTG [9-12].
It was recently suggested that the autoimmune system
plays  an  important  role  in  the  development  of  glaucoma,
especially  NTG.  Wax  [13]  proposed  that  the  role  of  the
immune  system  in  glaucoma  was  twofold  and  that  an
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1874autoimmune mechanism may elicit damage to the optic nerve,
resulting in glaucomatous injury. He additionally suggested
that autoimmune-mediated glaucoma injury occurs most often
in  NTG  patients.  There  have  been  several  reports  of
autoantibodies against ocular antigens that are upregulated in
the  serum  of  patients  with  glaucoma,  such  as  heat  shock
proteins (HSPs) [14], gamma-enolase [15], glutathione S-
transferase  [16],  anti-phosphatidylserine  [17],  and
glycosaminoglycans [18]. Therefore, NTG might actually be
an organ-specific autoimmune disorder.
Human  leukocyte  antigen  (HLA)  genes  regulate  the
immune system and the predisposition to most autoimmune
disorders.  HLA  class  II  alleles  have  been  shown  to  be
significantly associated with glaucoma. Gil-Carrasco et al.
[19] reported a higher frequency of the HLA-DR3 antigen in
Mexican POAG patients compared with controls; further, an
increased frequency of the HLA-DRB1*0407-DQB1*0302
haplotype  was  significantly  associated  with  POAG  in
Mexican patients [20]. Ferreri et al. [21] showed a significant
association between DR11 and DQ1 alleles and POAG in the
Italian  population.  Therefore,  HLA  class  II  gene
polymorphisms  may  influence  the  development  of
autoimmunity in glaucoma. On the other hand, HLA class I
alleles have also been shown to be associated with glaucoma
[22-24].  However  numerous  studies  have  reported  no
significant  correlation  between  HLA  class  I  alleles  and
glaucoma [25-28], and thus the possibility of HLA class I
alleles  being  associated  with  the  pathogenesis  of  NTG  is
deemed low.
The aim of this study was to clarify the role of HLA class
II  gene  polymorphisms  in  the  development  of  NTG  by
assessing the association of polymorphisms in HLA-DRB1
and HLA-DQB1 genes with NTG in Japanese patients.
METHODS
Subjects: We recruited 113 unrelated Japanese patients with
NTG and 184 unrelated healthy Japanese control subjects at
the  following  Japanese  universities:  Yokohama  City
University,  Yamanashi  University,  Gifu  University,  Kobe
University, Yamaguchi University, Kumamoto University,
Hokkaido University, Tokyo University, Niigata University,
Kanazawa  University,  Hiroshima  University,  Tajimi
municipal  hospital,  and  Tokai  University.  Patients  were
diagnosed using the following strict inclusion criteria: the
presence  of  glaucomatous  optic  neuropathy  with
corresponding visual field loss; normal open angle with angle
width of Shaffer grade 2 or higher; absence of IOP greater
than  21  mmHg  on  repeat  pressure  measurement  using
Goldmann applanation tonometry without medication; and
lack of a pathological basis for optic nerve changes upon
neurologic,  rhinologic,  and  general  medical  examination,
including magnetic resonance imaging. Glaucomatous optic
nerve change was diagnosed when the vertical cup/disc ratio
of the optic nerve head was 0.7 or higher, the rim width at the
superior (11 to 1 o’clock) or inferior (5 to 7 o’clock) position
was  less  than  or  equal  to  10%  of  the  disc  diameter,  the
difference in the vertical cup/disc ratio between eyes was 0.2
or  greater,  or  a  nerve  fiber  layer  defect  was  found.
Glaucomatous visual field loss was defined on a hemifield
basis using reliable field data examined by the Humphrey®
static visual field analyzer (HFA) C-30–2 program (Carl Zeiss
Meditec, Oberkochen, Germany) according to Anderson and
Patella’s criteria [29]. The hemifield was considered abnormal
when the pattern deviation probability plot revealed a cluster
of 3 or more non-edge contiguous points having sensitivity
with a probability of less than 5% in the upper or lower
hemifield, with one of these points having a probability of less
than 1%. In addition, the following inclusion and exclusion
criteria  were  used.  We  excluded  individuals  who  were
diagnosed when they were under 20 years old or over 60 years
old with a –8.0D or higher myopic refractive error of spherical
equivalence.  The  selection  criteria  for  the  HFA  mean
deviation were stratified depending on the subjects’ ages to
minimize the effect of aging on retinal ganglion cell loss and
subsequent visual field defects. Specifically, there was no
exclusion if the patient was diagnosed when under 50 years
old; when the patient was –10.00 dB or worse in at least one
eye but was diagnosed between the ages of 50 and 55 years;
or when the patients had –15.00 dB or worse in at least one
eye but the patient was over age 55 when diagnosed. Patients
with relatively early onset were selected because early onset
suggests a stronger involvement of genetic factors. During
diagnosis, patients were excluded if their refraction values had
changed due to cataract surgery, refractive surgery, etc. In
cases in which glaucomatous visual field loss was present in
only one eye, the refraction value and glaucomatous visual
field loss of the affected eye were used. In cases in which
glaucomatous visual field loss was present in both eyes, the
refraction value and glaucomatous visual field loss of the more
severely affected eye were used.
Patients ranged in age between 24 and 59 years (mean
47.4±6.9 years), and 47.8% were male. The mean refraction
value was –3.82±3.02 D, and the mean deviation observed in
the Humphrey® static visual field determination (Carl Zeiss
Meditec) was –10.15±8.01 dB. The control subjects were
healthy volunteers from a geographic region similar to that of
the NTG patients. They had no glaucoma or ophthalmological
or systemic diseases that might cause glaucoma or optic nerve
changes, and they had either no myopia or mild myopia with
refractive errors of –3.00 D or less. Of the control subjects,
44.6% were male.
HLA-DRB1 and HLA-DQB1 genotyping: Genotyping of the
HLA-DRB1 and HLA-DQB1 alleles was performed using the
PCR-SSOP  Luminex  method  using  LABType  SSO  (One
Lambda Inc., Canoga Park, CA), a reverse SSO DNA typing
system, according to the manufacturer’s instructions. Briefly,
target DNAs were PCR-amplified using HLA-DRB1 or HLA-
DQB1 group-specific primers. The biotinylated PCR products
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conjugated  to  fluorescently  coded  microspheres.  A  flow
analyzer,  LABScanTM  100,  identifies  the  fluorescent
intensity  of  phycoerythrin  on  each  microsphere.  The
determination of the HLA allele was based on the reaction
pattern compared to patterns associated with published HLA
allele sequences.
Statistical analysis: Allelic frequencies were determined by
direct counting. The significance of the allelic distribution
between the patients with NTG and normal controls was first
analyzed using Fisher’s exact probability test. The probability
of association was corrected by the Bonferroni inequality
method, i.e., by multiplying the p values with the number of
alleles. A corrected p (pc) value of <0.05 was considered
statistically significant.
Haplotype frequencies and linkage disequilibrium (LD)
in  the  multi-locus  analyses  were  calculated  using  PyPop
[30].  Haplotype  frequencies  were  determined  using  the
iterative  expectation-maximization  algorithm.  LD  was
measured using Hedrick’s multiallelic D´ statistic [31]. D´
weights the contribution of specific allele pairs to the LD using
the  product  of  their  allelic  frequencies.  The  measure  is
normalized to fall between zero and one, with higher values
indicating a stronger LD contribution.
RESULTS
The gene frequencies of HLA-DRB1 and HLA-DQB1 alleles
in 113 Japanese patients with NTG and in184 healthy control
subjects are shown in Table 1 and Table 2, respectively. A
total of 27 HLA-DRB1 alleles and 14 HLA-DQB1 alleles were
identified  in  NTG  patients  and  healthy  controls.  The
frequencies of HLA-DRB1*1301 and HLA-DQB1*0603 were
higher in patients with NTG compared with healthy controls,
although this increase did not reach statistical significance
after  performing  the  Bonferroni  correction.  We  found  no
significant differences in the frequency of other HLA-DRB1
and HLA-DQB1 alleles between the patients and controls.
The magnitude of LD between HLA-DRB1 and HLA-
DQB1  was  extremely  high,  with  a  pair-wise  D´>0.85.
TABLE 1. ALLELE FREQUENCIES OF HLA-DRB1 IN JAPANESE PATIENTS WITH NORMAL TENSION GLAUCOMA.
  Frequency, n (%)    
HLA-DRB1 Cases (n=113) Controls (n=184) p pc
0101 17 (7.5) 20 (5.4) 0.38  
0301 0 (0.0) 1 (0.3) 1  
0401 0 (0.0) 1 (0.3) 1  
0403 6 (2.7) 12 (3.3) 0.81  
0405 27 (11.9) 43 (11.7) 1  
0406 5 (2.2) 11 (3.0) 0.79  
0407 1 (0.4) 3 (0.8) 1  
0410 8 (3.5) 7 (1.9) 0.28  
0802 12 (5.3) 23 (6.3) 0.72  
0803 15 (6.6) 30 (8.2) 0.53  
0901 30 (13.3) 54 (14.7) 0.72  
1001 2 (0.9) 0 (0.0) 0.14  
1101 5 (2.2) 8 (2.2) 1  
1201 9 (4.0) 12 (3.3) 0.65  
1202 7 (3.1) 8 (2.2) 0.59  
1301 5 (2.2) 1 (0.3) 0.032 NS
1302 16 (7.1) 28 (7.6) 0.87  
1303 0 (0.0) 1 (0.3) 1  
1307 0 (0.0) 1 (0.3) 1  
1401 7 (3.1) 13 (3.5) 1  
1403 1 (0.4) 5 (1.4) 0.42  
1405 2 (0.9) 7 (1.9) 0.49  
1406 4 (1.8) 3 (0.8) 0.44  
1412 0 (0.0) 1 (0.3) 1  
1501 17 (7.5) 23 (6.3) 0.61  
1502 28 (12.4) 48 (13.0) 0.90  
1602 2 (0.9) 4 (1.1) 1  
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 Haplotype  analyses  indicated  complete  LD  between  the
HLADRB1*1301 and HLA-DQB1*0603 alleles, and the HLA-
DRB1*1301-HLA-DQB1*0603 haplotype had an increased
frequency in patients; this was not significant after correction
(Table 3).
DISCUSSION
Several studies have reported associations between HLA and
glaucoma, and others have suggested that HLA class II genes
may have an effect on the development of POAG [19-21]. The
aim of this study was to investigate whether specific alleles in
the HLA class II genes affected the development of NTG,
which was recently suggested to be an autoimmune disorder.
Toward this end, we genotyped the HLA-DRB1 and HLA-
DQB1 genes in Japanese NTG patients and in healthy control
subjects.
In contrast to previous POAG studies, this study focused
on NTG and did not find an allelic distribution of HLA class
II genes that was statistically different between NTG patients
and  controls.  Although  the  frequencies  of  the  HLA-
DRB1*1301  and  HLA-DQB1*0603  alleles  and  the  HLA-
DRB1*1301-HLA-DQB1*0603 haplotype was higher in NTG
patients, these increases were not statistically significance
after the Bonferroni correction. These HLA types were not
consistent with POAG-associated HLA types. In addition, the
frequency  of  POAG-associated  HLA  types  was  not
significantly different in patients and controls in this NTG
study,  and  these  HLA  types  are  rare  in  the  Japanese
population.
Our NTG study did not replicate the results of previous
POAG studies, most likely because NTG and POAG have
distinct  characteristics.  The  genes  affecting  the  immune
systems of NTG patients may differ from those affecting
POAG patients. In addition, the distribution of the alleles of
HLA genes is different for each ethnic group. It is possible
that there were false-positive results in the earlier POAG
TABLE 2. ALLELE FREQUENCIES OF HLA-DQB1 IN JAPANESE PATIENTS WITH NORMAL TENSION GLAUCOMA.
  Frequency, n (%)    
HLA-DQB1 Cases (n=113) Controls (n=184) p pc
0201 0 (0.0) 1 (0.3) 1  
0301 22 (9.7) 37 (10.1) 1  
0302 21 (9.3) 40 (10.9) 0.58  
0303 35 (15.5) 57 (15.5) 1  
0401 26 (11.5) 40 (10.9) 0.89  
0402 14 (6.2) 20 (5.4) 0.72  
0501 19 (8.4) 21 (5.7) 0.24  
0502 5 (2.2) 10 (2.7) 0.79  
0503 6 (2.7) 15 (4.1) 0.49  
0601 42 (18.6) 77 (20.9) 0.53  
0602 14 (6.2) 21 (5.7) 0.86  
0603 5 (2.2) 1 (0.3) 0.032 NS
0604 16 (7.1) 28 (7.6) 0.87  
0611 1 (0.4) 0 (0.0) 0.38  
TABLE 3. FREQUENCIES OF DRB1-DQB1   HAPLOTYPES IN JAPANESE PATIENTS WITH NORMAL TENSION GLAUCOMA (NTG).
  Frequency, n (%)    
Haplotype* Cases (n=113) Controls (n=184) p pc
DRB1*0901:DQB1*0303 29 (12.8) 53 (14.4) 0.63  
DRB1*1502:DQB1*0601 28 (12.4) 47 (12.8) 1  
DRB1*0405:DQB1*0401 26 (11.5) 40 (10.9) 0.89  
DRB1*1302:DQB1*0604 16 (7.1) 28 (7.6) 0.87  
DRB1*0803:DQB1*0601 14 (6.2) 29 (7.9) 0.52  
DRB1*0101:DQB1*0501 17 (7.5) 20 (5.4) 0.38  
DRB1*1501:DQB1*0602 14 (6.2) 19 (5.2) 0.59  
DRB1*1301:DQB1*0603 5 (2.2) 1 (0.3) 0.032 NS
        *Only haplotypes that reached frequencies >5% in all subjects or that may have an effect on the development of NTG are shown.
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design is required to observe reliable positive associations.
Further, the studies must be performed using adequate sample
sizes, careful multiple testing correction, and LD analysis.
Although  Gil-Carrasco  et  al.  [19]  and  Ferreri  et  al.  [21]
reported the associations of HLA class II alleles with POAG,
the sample sizes in those studies were not big enough to
support their positive findings, since positive results in small
studies have a high risk of being false-positives. In another
study that reported a significant association between the HLA-
DRB1*0407-HLA-DQB1*0302 haplotype and POAG [20],
the p values were corrected by the Yates method but not by
multiple  testing;  this,  too,  might  lead  to  a  false  positive
association. In addition, the study reported that the estimated
frequency  for  the  HLA-DRB1*0407-  HLA-DQB1*0302
haplotype in the POAG patients was 25.9%, much higher than
the 15.4% frequency reported for the HLA-DRB1*0407 allele
in the patients. Based on the allele frequency shown in the
study, it is possible that actual frequency of the haplotype was
less  than  estimated  and  that  the  haplotype  may  be  not
associated with POAG. Recently, Yano et al. [32] reported a
possible association between the HLA-DRB1*1502 allele and
the presence of anti-neurofilament light subunit antibodies in
a patient group that included POAG and NTG patients; no
correction  was  performed.  However,  if  the  Bonfferoni
correction is applied to that study, the adjusted p value would
be greater than 0.05.
It thus remains unclear whether the HLA class II genes
have  an  effect  on  the  pathogenesis  of  glaucoma.  Several
clinical and experimental glaucoma studies have focused on
the role of the immune system in glaucoma; results strongly
suggest that activated immunity contributes to glaucomatous
optic neuropathy [33]. Cartwright et al. [34] reported that 30%
of NTG patients had one or more immune-related diseases
compared to 8% of control patients with ocular hypertension.
This suggests that the immune system plays a role in the
development of NTG. It is likely that multiple immune-related
genes are associated with NTG. For example, the toll-like
receptor 4 gene encodes a protein that recognizes heat shock
proteins and lipopolysaccharides and is critical for the innate
and  adaptive  immune  systems.  We  recently  reported  that
polymorphisms in this gene affected the development of NTG
[35]. However, there are no reports of a significant association
between other immune-related genes and NTG. In the future,
carefully  designed  studies  will  be  essential  to  determine
whether  other  immune-related  genes  contribute  to  the
pathogenesis of NTG.
In  conclusion,  we  found  no  significant  associations
between the genes HLA-DRB1 and HLA-DQB1 and NTG in
the Japanese population. These genes do not appear to be
associated with the pathogenesis of NTG. However, because
there are differences in the distribution of alleles of HLA
genes  in  different  ethnic  groups,  the  association  between
genes and NTG should also be assessed in other ethnic groups.
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